Endometrin Articles
Watson to acquire US rights to Columbia Labs' Crinone and Prochieve for up to $92 million
5 March 2010
Watson gains exclusive US rights to HRA Pharma’s ulipristal and Abbott makes deal with Fabre for MAb
2 February 2010
Profit plummets 55% for Solvay in recession
15 May 2009
HRA and PregLem drug improves QoL in UF
12 May 2009
B-MS' Ixempra increases PFS in triple negative BC
22 December 2008
Repros Thera enters $15.6M financing deal
6 October 2008
PregLem initiates Ph III uterine myoma trial
1 September 2008
Repros' Proellex sees strong Ph II data
21 July 2008
HRA Pharma in licensing deal with PregLem for ulipristal
10 December 2007
Hi-Tech licenses asthma drug from Biomarin
23 July 2007
Ferring's Endometrin approved in USA
2 July 2007
Ph IIIa NOMAC/E2 trial completes recruitment
28 May 2007
Ferring's Endometrin effective in IVF trial
30 April 2007
Columbia Labs raises $40 million
8 January 2007
Indian Pharma cuts 886 drug prices
13 November 2006
FDA grants Gestiva NDA priority status
19 June 2006
Richter and Repros in supply deal for Proellex
29 May 2006
Why estrogenic hormones induce different responses in women
28 February 2005
Solvay awarded $68 million in Barr dispute
28 June 2004
Aromasin prolongs breast cancer survival
29 March 2004
UK NHS to offer free IVF treatment
1 March 2004
Serono beats expectations with 3rd-qtr 2003 net income up 48%
3 November 2003
Zonagen grant for Ph I Progenta trial
5 August 2002
Serono agrees to Crinone settlement
10 June 2002
Stock Commentary - Europe
10 June 2002
Bayer offers license opportunity
29 April 2002
Serono reports 10.4% 1st-qtr sales increase
29 April 2002
Serono relaunches Crinone in USA
18 March 2002
Serono's 2001 5.2% net income rise below consensus forecasts
18 February 2002
Crinone not ready for re-introduction?
6 December 2001
Serono reports disappointing sales
31 October 2001
Schering AG launches Yasmin OC in USA
26 June 2001
Schering AG's Climodien approved in EU
12 June 2001
Minulet OC launched in China
31 May 2001
Schering AG's Yasmin registered in USA
21 May 2001
Serono makes strong start to 2001
2 May 2001
Serono recalls some batches of Crinone
6 April 2001
Europe approves Schering's Yasmin, US approvable letter for Imavist
7 September 2000
Serono sees 2nd-qtr net income leap 60%
21 July 2000
Schering's Yasmin approved in the Netherlands
13 April 2000
Parkinson's market "may double by 2008"
22 February 2000
Ligand earns milestone from Wyeth-Ayerst
5 January 2000
FDA backs new dose of Solvay's Prometrium
21 October 1999
Crinone first alternative to injections in ART
30 September 1999
Estrogen-free contraceptive in development at Ligand
23 September 1999
A-S licenses fertility drug from AHP
15 June 1999
Galen plans vaginal ring launch within a year
28 May 1999
New indication for Solvay's Prometrium - updated story
7 January 1999
FDA approves Solvay's Prometrium
22 December 1998
Ligand Unveils SARMs For Endocrine Therapy
26 June 1998
Solvay's Prometrium Cleared In USA
21 May 1998
Wyeth-Ayerst Launches Crinone In USA
14 May 1998
Stock Commentary Tokyo
30 April 1998
Columbia's Crinone Cleared In USA
7 August 1997
Columbia Labs' Crinone Approved In USA
19 May 1997
Ligand Pharma Converts AHP Loan To Stock
7 October 1996
Vaccine Strategy For Trichomonas?
30 September 1996
Columbia Files NDA For Crinone In USA
5 August 1996
Akzo To Seek Global Approval Of Contraceptive Ring
10 June 1996
Columbia Plans Crinone Submission Soon
6 May 1996
Upbeat Alza Unveils Revamped Pipeline
19 February 1996
Columbia Labs: Crinone news
22 January 1996
Ligand and Wyeth-Ayerst expand collab
22 January 1996
Neurocrine: Nervous System Product Profile
2 October 1995
Schering-Plough Is "Right-Sized And Flexible"
3 July 1995
Columbia/AHP Crinone agreement
5 June 1995
Upjohn suing AHP for infringment on Provera
22 May 1995
Roussel-Uclaf Details Group Pipeline Plans
10 April 1995
Zoladex Backed By FDA Committee
27 February 1995
Mifepristone And Meningioma
3 October 1994
Wyeth-Ayerst To Take Annuelle Into Ph III
26 September 1994
Contraceptive Trial And Breast Cancer
18 July 1994
COCENSYS FILES INDs FOR ANTICONVULSANT
20 December 1993
NEW FORMULATION OF B-MS' MEGACE
27 September 1993
BRIGHT FUTURE FOR HEALTH CARE AT SOLVAY
12 July 1993
WHO APPROVES SHORT-TERM CONTRACEPTION INJECTION
28 June 1993
COCENSYS TARGETING NEUROACTIVE STEROIDS
19 April 1993
SHIFTS FORECAST IN US CONTRACEPTIVES MARKET
3 August 1992
ROUSSEL-UCLAFS MIFEGYNE
16 March 1992
RU's DIMETROSE FOR CYCLIC MASTALGIA
3 February 1992
CANADIAN TRIAL WITH MIFEGYNE
6 January 1992
Showing 1-94 of 94 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
